Modifying immune responses to adeno-associated virus vectors by capsid engineering-Reference-Cited by-同舟云学术

Modifying immune responses to adeno-associated virus vectors by capsid engineering

Published:2023-09 Issue: Volume:30 Page:576-592
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Bentler Martin,Hardet Romain,Ertelt Moritz,Rudolf Daniela,Kaniowska Dorota,Schneider Andreas,Vondran Florian W.R.,Schoeder Clara T.,Delphin Marion,Lucifora Julie,Ott Michael,Hacker Ulrich T.,Adriouch Sahil,Büning Hildegard

Funder

German Research Foundation

Federal Ministry of Education and Research Bonn Office

Sächsisches Staatsministerium für Wissenschaft und Kunst

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference60 articles.

1. The clinical landscape for AAV gene therapies;Kuzmin;Nat. Rev. Drug Discov.,2021

2. Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?;Keeler;Annu. Rev. Virol.,2019

3. Eladocagene Exuparvovec: First Approval;Keam;Drugs,2022

4. First conditional marketing authorization approval in the European Union for hemophilia "A" gene therapy;VandenDriessche;Mol. Ther.,2022

5. First hemophilia B gene therapy approved: More than two decades in the making;Herzog;Mol. Ther.,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector;Frontiers in Immunology;2024-09-12

2. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

3. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

4. Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects;Biomedicines;2024-07-09

5. AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy;Microorganisms;2023-12-14